REGISTERED
on 14 May 2024
Last Applicant/ Owned by
B-304, Ganga Elika Society,
Kad Nagar, Undri Pune,
IN
411060
Serial Number
97394409 filed on 04th May 2022
Registration Number
7383820 registered on 14th May 2024
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
PRORELIX RESEARCH
Clinical research in the field of Pharma, Biotech, Biopharma, Medical devices, Nutraceutical and Herbal domain; Development of pharmaceutical preparations and medicines; Information technology consulting services; Pharmaceutical drug development services; Pharmaceutical research services; Research and development and consultation related thereto in the field of Pharma, Biotech, Biopharma, Medical Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Pharmaceutical compounding services
First Use Date in General
04th Aug 2017
First Use Date in Commerce
04th Aug 2017
Class [042]
Computer & Software Services & Scientific Services
Clinical research in the field of Pharma, Biotech, Biopharma, Medical devices, Nutraceutical and Herbal domain; Development of pharmaceutical preparations and medicines; Information technology consulting services; Pharmaceutical drug development services; Pharmaceutical research services; Research and development and consultation related thereto in the field of Pharma, Biotech, Biopharma, Medical devices, Nutraceutical and Herbal domain; Research and development in the field of Pharma, Biotech, Biopharma, Medical devices, Nutraceutical and Herbal domain; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of technology in the field of Pharma, Biotech, Biopharma, Medical devices, Nutraceutical and Herbal domain; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Basic and clinical research in the field of respiratory science and medicine; Biochemical research and development; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Consulting services in the field of pharmaceutical research; Consulting services in the field of pharmaceutical research and development; Consulting in the field of information technology; Laboratory research services relating to pharmaceuticals; Medical and scientific research, namely, conducting clinical trials for others; Outsource service provider in the field of information technology consulting; Outsource service providers in the field of information technology; Pharmaceutical research and development; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research and development; Scientific research in the nature of conducting clinical trials for others; Scientific research in the nature of conducting clinical trials for others in the field of Pharma, Biotech, Biopharma, Medical devices, Nutraceutical and Herbal domain; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
First Use Date in General
04th Aug 2017
First Use Date in Commerce
04th Aug 2017
Mark Details
Serial Number
No 97394409
Mark Type
No Service Mark
Attorney Docket Number
No 234-19-TUS
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.09.16 -
Squares touching or intersecting
Legal History
| Status Date | Action Taken |
|---|---|
| 14th May 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 14th May 2024 | REGISTERED-PRINCIPAL REGISTER |
| 04th Mar 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 27th Feb 2024 | PUBLISHED FOR OPPOSITION |
| 07th Feb 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 07th Feb 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 22nd Jan 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 20th Dec 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 20th Dec 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 20th Dec 2023 | ASSIGNED TO LIE |